Orthognathic surgery, affecting the jaws and face, requires a balancing act in anesthetic technique. Limiting blood loss, avoiding respiratory depression, and averting postoperative nausea and vomiting lead to optimum patient outcomes. The use of the drugs propofol and remifentanil are increasing because they can meet these needs; however, patients may subsequently experience more postoperative pain.
The journal Anesthesia Progress presents a retrospective study of 51 patients in a single medical center. The 21 orthognathic maxillofacial surgery patients in the group receiving intravenous propofol and remifentanil experienced significantly higher pain scores. Anesthesia for the 30 patients in the comparison group was maintained with inhalational agents and longer-acting opioids.
The drug remifentanil is seeing increased use in orthognathic surgery because its short half-life can facilitate stable operating conditions while avoiding the undesirable postoperative consequences of morphine and other such agents. There is still a need for pain control in the postoperative period using longer-acting opioids that carry a greater potential for adverse effects.
The study was undertaken to ensure that achieving better intraoperative conditions did not come at the expense of patients’ recovery. Variables of comparison included recovery time, occurrence of nausea and vomiting, pain scores, heart rate, and opioid dose administered in the 4 hours following surgery.
There was a trend toward shorter recovery times in the group receiving propofol and remifentanil. The median recovery time was 65 minutes for this group and 93 minutes for the inhalation group. However, the first group reported higher pain scores in the first 4 hours following surgery. No differences were found in early postoperative opioid use, heart rate, or nausea and vomiting.
With maxillofacial surgery, postoperative respiratory and gastrointestinal complications can be dangerous. While turning to drugs that can reduce these risks leads to better surgical experiences, it may also mean increased postoperative pain for patients. This study takes a first look at this occurrence and may be the stimulus for future controlled studies.
Full text of “The Effect of Anesthetic Technique on Recovery After Orthognathic Surgery: A Retrospective Audit,” and other articles, Anesthesia Progress, Vol. 59, No. 2, 2012, are available at http://www.anesthesiaprogress.org/toc/anpr/59/2
Anesthesia Progress is the official publication of the American Dental Society of Anesthesiology (ADSA). The quarterly journal is dedicated to providing a better understanding of the advances being made in the science of pain and anxiety control in dentistry. The journal invites submissions of review articles, reports on clinical techniques, case reports, and conference summaries.
(Source: Anesthesia Progress)
NEW YORK, N.Y., USA: The ideal sedative for oral surgery should make the patient comfortable during the surgery and should wear off quickly enough that the ...
More than any other specialty, general dentists refer their patients to specialists for orthodontic treatment. In Australia, the options given to these ...
CHARLOTTE, N.C., USA: As part of Dentsply Sirona’s continued pledge to create healthy practices for healthy smiles and drive practice recovery, the Dental...
When it comes to treatment acceptance — or lack thereof — it seems as though a lot of time and energy are wasted on that familiar trio ...
The economy is slowly recovering from the worst recession in decades. Like many other small businesses, dental practices have been adversely affected. Many ...
To make the wait for ROOTS SUMMIT 2024 a little sweeter, the organisers would like to spotlight some of the speakers for next year’s edition, which will ...
MELVILLE, N.Y., USA: Henry Schein Inc. announced today (May 21, 2020) the Henry Schein Recovery Pricing Plan, offering discounts of as much as 18 percent ...
Dentists today are living during exciting times when advancements in materials, techniques and diagnostics allow us to predictably improve the quality of ...
Capt-all, a handheld device that captures amalgam waste at the source — the patient’s mouth — and meets the EPA’s requirements for an “equivalent ...
NEW YORK, NY, USA/LEIPZIG, Germany: The US-based manufacturer AMD LASERS recently launched the Picasso Lite in dental markets worldwide. As a first in the ...
Live webinar
Thu. 18 July 2024
8:00 PM EST (New York)
Live webinar
Tue. 6 August 2024
6:00 PM EST (New York)
Live webinar
Tue. 13 August 2024
7:00 PM EST (New York)
Live webinar
Wed. 14 August 2024
12:30 PM EST (New York)
Live webinar
Wed. 21 August 2024
9:00 AM EST (New York)
Dr. Jim Lai DMD, MSc(Perio), EdD, FRCD(C)
Live webinar
Wed. 28 August 2024
8:00 PM EST (New York)
Live webinar
Mon. 2 September 2024
5:00 AM EST (New York)
To post a reply please login or register